Journal of Personalized Medicine (Jan 2021)

A Predictive Model and Risk Factors for Case Fatality of COVID-19

  • Melchor Álvarez-Mon,
  • Miguel A. Ortega,
  • Óscar Gasulla,
  • Jordi Fortuny-Profitós,
  • Ferran A. Mazaira-Font,
  • Pablo Saurina,
  • Jorge Monserrat,
  • María N. Plana,
  • Daniel Troncoso,
  • José Sanz Moreno,
  • Benjamin Muñoz,
  • Alberto Arranz,
  • Jose F. Varona,
  • Alejandro Lopez-Escobar,
  • Angel Asúnsolo-del Barco

DOI
https://doi.org/10.3390/jpm11010036
Journal volume & issue
Vol. 11, no. 1
p. 36

Abstract

Read online

This study aimed to create an individualized analysis model of the risk of intensive care unit (ICU) admission or death for coronavirus disease 2019 (COVID-19) patients as a tool for the rapid clinical management of hospitalized patients in order to achieve a resilience of medical resources. This is an observational, analytical, retrospective cohort study with longitudinal follow-up. Data were collected from the medical records of 3489 patients diagnosed with COVID-19 using RT-qPCR in the period of highest community transmission recorded in Europe to date: February–June 2020. The study was carried out in in two health areas of hospital care in the Madrid region: the central area of the Madrid capital (Hospitales de Madrid del Grupo HM Hospitales (CH-HM), n = 1931) and the metropolitan area of Madrid (Hospital Universitario Príncipe de Asturias (MH-HUPA) n = 1558). By using a regression model, we observed how the different patient variables had unequal importance. Among all the analyzed variables, basal oxygen saturation was found to have the highest relative importance with a value of 20.3%, followed by age (17.7%), lymphocyte/leukocyte ratio (14.4%), CRP value (12.5%), comorbidities (12.5%), and leukocyte count (8.9%). Three levels of risk of ICU/death were established: low-risk level (20%). At the high-risk level, 13% needed ICU admission, 29% died, and 37% had an ICU–death outcome. This predictive model allowed us to individualize the risk for worse outcome for hospitalized patients affected by COVID-19.

Keywords